BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
HCL Technologies Ltd. reported healthy margins in Q3 FY21 and were above our estimates.
The company has also revised its margins guidance upwards from 20-21% in FY21E to 21-21.5%.
Revenues were in line with our estimate at 3.5% QoQ in constant currency terms, while margins were above our estimates.
The company has signed 13 transformational deals across industry verticals, including Life Sciences and Healthcare, Technology and Financial Services.
The company has declared a dividend of Rs 4 per share.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.